Skip to content
Screener

Humana HUM Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

CVS Health logo
CVS HealthCVS
$169M—
Alignment Healthcare logo
Alignment HealthcareALHC
$0—
Teladoc Health logo
Teladoc HealthTDOC
$3.63M-26.2%

Other financials

Income statement

See full
Revenue$40.9B+26.2%
Operating income$1.4B+23.9%
Net income$694.0M+27.3%
EPS (diluted)$5.73+27.1%

Balance sheet

See full
Cash & equivalents$6.9B+70.6%
Total debt$14.2B+13.2%
Total equity$19.2B+5.4%
Total assets$57.2B+13.6%

Cash flow

See full
Operating cash flow$2.0B+54.7%
CapEx$132.0M+15.8%
Free cash flow$1.8B+58.5%

Valuation

See full
Market cap$46.31B+44.4%
Enterprise value$53.67B+32.1%
P/E17.7×-2.2×
P/S0.3×+0.1×

Profitability

See full
Operating margin2.7%-1.7pp
Net margin3%-0.1pp
FCF margin4.2%—

Returns & leverage

See full
Return on equity18.2%+0.9pp
Debt / equity0.7×+0.1×
Current ratio1.7×-0.2×

Where this comes from

Reported directly by Humana in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The source filing: Humana’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 2:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000049071-26-000050
Line itemJune 30,2026December 31, 2025
Current assets:
Cash and cash equivalents$6,893$4,200
Investment securities16,97815,703
Receivables, net of allowances of $117 in 2026 and $108 in 20255,6953,270
Other current assets10,5209,560
Total current assets40,08632,733
Property and equipment, net2,0982,231
Long-term investment securities650493

Item 6. Exhibits [53](#ia86f76420e744c99a4e0b1c9d7af6cd5_127)

FAQ

What is Humana's allowance for doubtful accounts receivable (current)?
Humana (HUM) reported allowance for doubtful accounts receivable (current) of $117M in Q2 2026.
How has Humana's allowance for doubtful accounts receivable (current) changed year-over-year?
Humana's allowance for doubtful accounts receivable (current) decreased by 18.2% year-over-year, from $143M to $117M.
What is the long-term trend for Humana's allowance for doubtful accounts receivable (current)?
Over 5 years (2020 to 2025), Humana's allowance for doubtful accounts receivable (current) has grown at a 8.4% compound annual growth rate (CAGR), from $72M to $108M.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.

Ask your AI about Humana's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude